Bupropion as an Antidote for Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction
J Clin Psychiatry 1998;59:112-115
© Copyright 2014 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Background: Serotonin reuptake inhibiting
antidepressants (SRIs) are reported to cause sexual dysfunctions,
including reduction in desire, arousal, and orgasm. This study
evaluates the efficacy of bupropion in ameliorating sexual
dysfunctions in patients receiving SRIs.
Method: Forty-seven patients in an outpatient
psychiatric practice who complained of SRI-induced sexual
dysfunction accepted a trial of bupropion as an adjunct to their
SRI, either as a p.r.n. or as a fixed-dose scheduled medicine.
Patients received 75 mg or 150 mg of bupropion 1 to 2 hours
before sexual activity. If this was insufficient to reduce their
complaints, dose was increased gradually to 75 mg t.i.d. and
sustained for 2 weeks. This regimen was then continued if
Results: Bupropion successfully reversed a
variety of sexual dysfunctions caused by SRIs in 31 (66%) of 47
patients. Fifty-two (69%) of 75 sexual complaints improved with
bupropion treatment. The p.r.n. use of bupropion assisted 18
(38%) of 47 patients. Side effects of anxiety and tremor led to
discontinuation of bupropion in 7 (15%) of 47 patients.
Otherwise, bupropion was well tolerated.
Conclusion: Bupropion administration may be a
safe and effective method of treating SRI-induced sexual
dysfunction. Placebo-controlled, double-blind studies are needed.